The effects of platelet apheresis on blood coagulation function in bilateral total hip arthroplasty: a prospective randomized study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15007051

Enrollment

Unknown

Registered

2015-09-07

Start date

2014-09-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

double hip osteoarthritis

Interventions

Group PRP:platelet apheresis

Control Group:autotransfusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 18 to 65 years, a1-2, preoperative platelet count in the normal range,hemoglobin more than 120g/l, informed consent signed.

Exclusion criteria

Exclusion criteria: Cardiorespiratory dysfunction, blood coagulation disorder, blood tem diseases, liver kidney dysfunction, low blood volume,taking anticoagulant drugs platelet inhibitors within 2 weeks.infection thrombosis disease.

Design outcomes

Primary

Measure	Time frame
blood loss;transfusion volume;	—

Countries

China

Contacts

Public ContactJun Ma

majun7689@163.com+86 13811031060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026